Pharsight

Drugs that contain Oxymorphone Hydrochloride

1. Opana Er patents expiration

OPANA ER's oppositions filed in EPO
OPANA ER Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7851482 ENDO PHARMS Method for making analgesics
Jul, 2029

(5 years from now)

US8871779 ENDO PHARMS Process for preparing morphinan-6-one products with low levels of α,β-unsaturated ketone compounds
Nov, 2029

(5 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5958456 ENDO PHARMS Controlled release formulation (albuterol)
Sep, 2013

(10 years ago)

US5662933 ENDO PHARMS Controlled release formulation (albuterol)
Sep, 2013

(10 years ago)

US8309122 ENDO PHARMS Oxymorphone controlled release formulations
Feb, 2023

(1 year, 2 months ago)

US8309112 ENDO PHARMS Coatings for implantable medical devices comprising hydrophilic substances and methods for fabricating the same
Feb, 2023

(1 year, 2 months ago)

US8329216 ENDO PHARMS Oxymorphone controlled release formulations
Feb, 2023

(1 year, 2 months ago)

US7276250 ENDO PHARMS Sustained release formulations of oxymorphone
Feb, 2023

(1 year, 2 months ago)

US8309060 ENDO PHARMS Abuse-proofed dosage form
Nov, 2023

(4 months ago)

US8075872 ENDO PHARMS Abuse-proofed dosage form
Nov, 2023

(4 months ago)

US8114383 ENDO PHARMS Abuse-proofed dosage form
Aug, 2024

(3 months from now)

US8192722 ENDO PHARMS Abuse-proof dosage form
Sep, 2025

(1 year, 4 months from now)

US8808737 ENDO PHARMS Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment
Jun, 2027

(3 years from now)

Market Authorisation Date: 22 June, 2006

Treatment: Relief of moderate to severe pain; Dose modification for renal impairment

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage

OPANA ER family patents

Family Patents